First-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode.

Stähli, Patrick; Becchetti, Chiara; Korta Martiartu, Naiara; Berzigotti, Annalisa; Frenz, Martin; Jaeger, Michael (2023). First-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode. Communications medicine, 3(1), p. 176. Springer Nature 10.1038/s43856-023-00409-3

[img]
Preview
Text
s43856-023-00409-3.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

BACKGROUND

Non-alcoholic fatty liver disease is rapidly emerging as the leading global cause of chronic liver disease. Efficient disease management requires low-cost, non-invasive techniques for diagnosing hepatic steatosis accurately. Here, we propose quantifying liver speed of sound (SoS) with computed ultrasound tomography in echo mode (CUTE), a recently developed ultrasound imaging modality adapted to clinical pulse-echo systems. CUTE reconstructs the spatial distribution of SoS by measuring local echo phase shifts when probing tissue at varying steering angles in transmission and reception.

METHODS

In this first-in-human phase II diagnostic study, we evaluated the liver of 22 healthy volunteers and 22 steatotic patients. We used conventional B-mode ultrasound images and controlled attenuation parameter (CAP) to diagnose the presence (CAP≥ 280 dB/m) or absence (CAP < 248 dB/m) of steatosis in the liver. A fully integrated convex-probe CUTE implementation was developed on the ultrasound system to estimate liver SoS. We investigated its diagnostic value via the receiver operating characteristic (ROC) analysis and correlation to CAP measurements.

RESULTS

We show that liver CUTE-SoS estimates correlate strongly (r = -0.84, p = 8.27 × 10-13) with CAP values and have 90.9% (95% confidence interval: 84-100%) sensitivity and 95.5% (81-100%) specificity for differentiating between normal and steatotic livers (area under the ROC curve: 0.93-1.0).

CONCLUSIONS

Our results demonstrate that liver CUTE-SoS is a promising quantitative biomarker for diagnosing liver steatosis. This is a necessary first step towards establishing CUTE as a new quantitative add-on to diagnostic ultrasound that can potentially be as versatile as conventional ultrasound imaging.

Item Type:

Journal Article (Original Article)

Division/Institute:

08 Faculty of Science > Institute of Applied Physics
08 Faculty of Science > Institute of Applied Physics > Biomedical Photonics
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine
08 Faculty of Science > Other Institutions > Teaching Staff, Faculty of Science

UniBE Contributor:

Stähli, Patrick, Becchetti, Chiara, Korta Martiartu, Naiara, Berzigotti, Annalisa, Frenz, Martin, Jaeger, Michael

Subjects:

600 Technology > 620 Engineering
500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health
000 Computer science, knowledge & systems

ISSN:

2730-664X

Publisher:

Springer Nature

Language:

English

Submitter:

Pubmed Import

Date Deposited:

11 Dec 2023 14:55

Last Modified:

17 Dec 2023 02:32

Publisher DOI:

10.1038/s43856-023-00409-3

PubMed ID:

38071269

BORIS DOI:

10.48350/190121

URI:

https://boris.unibe.ch/id/eprint/190121

Actions (login required)

Edit item Edit item
Provide Feedback